(Press-News.org) Contact information: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-525-6383
Brigham and Women's Hospital
Scientists develop way to successfully give nanoparticle therapeutics orally
Findings will allow for more targeted, convenient drug delivery to treat chronic diseases, like diabetes
Boston, MA – Pop a pill or be poked by a needle? Being able to orally deliver microscopic particles—know as nanoparticles—loaded with medicine is a simple, convenient way to treat patients for various diseases, such as cancer or diabetes. But so far, nanoparticles can only be given via injection since they have trouble being readily absorbed by the intestine, which limits their usefulness.
Now a study led by researchers at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology (MIT) is the first to report in the field of nanomedicine a new type of nanoparticle that can be successfully absorbed through the digestive tract. The findings may one day allow patients to simply take a pill instead of receiving injections.
The study will be published online November 27, 2013 in Science Translational Medicine.
The nanoparticles developed by the researchers are decorated with antibodies that attach to receptors found on the cell surfaces that line the intestines. Once attached, the nanoparticles gain entry past the cellular barriers in intestinal walls and into the bloodstream. According to the researchers, this type of drug delivery could also be useful in developing new treatments for conditions such as high cholesterol or arthritis.
"The novelty of actively being able to transport targeted nanoparticles across cell barriers can potentially open up a whole new set of opportunities in nanomedicine," said Omid Farokhzad, MD, director of the BWH Laboratory of Nanomedicine and Biomaterials, senior study author. "The body has receptors that are involved in shuttling proteins across barriers, as is the case in the placenta between the mother and fetus, or in the intestine, or between the blood and the brain. By hitching a ride from these transporters the nanoparticles can enter various impermeable tissues."
Until recently, after being injected into the body, nanoparticles travelled to their destination, such as a tumor, by seeping through leaky vessels. The research team, led by Farokhzad and Robert Langer, ScD of MIT, developed nanoparticles that could reach the target site without relying on injection nor leaky vessels.
For nanoparticles to be taken orally they need to cross the intestinal lining. This lining is composed of a layer of epithelial cells joined together to form impenetrable barriers called tight junctions. To ensure that the nanoparticles could cross these barriers, the researchers took a cue from research on how babies absorb antibodies from their mothers' milk. The antibodies would grab onto a receptor, known as neonatal Fc receptors, found on the cell surface. This gave them access across the cells of the intestinal lining into neighboring blood vessels.
Based on this knowledge, the researchers decorated nanoparticles with Fc proteins that targeted and bound to these receptors, which are also found in adult intestinal cells. After attaching to the receptors, the Fc-protein-decorated nanoparticles—toting their drug payload—are all absorbed into the intestinal lining and into the bloodstream at a high concentration.
According to the researchers, these receptors can be used to transport nanoparticles carrying different kinds of drugs and other materials—a feat that combines a versatile vehicle and an easily accessible passageway across cellular barriers.
To demonstrate how transport of Fc-targeted nanoparticles could impact the clinical space, the researchers focused on a diabetes treatment scenario, showing how oral delivery of insulin via these targeted nanoparticles could alter blood sugar levels in mice.
Insulin carried in nanoparticles decorated with Fc proteins reached the bloodstream more efficiently than those without the proteins. Moreover, the amount of insulin delivered was large enough to lower the mice's blood sugar levels. Aside from insulin, the researchers note that the nanoparticles can be used to carry any kind of drug to treat many diseases.
"Being able to deliver nanomedicine orally would offer clinicians broad and novel ways to treat today's many chronic diseases that require daily therapy, such as diabetes and cancer," said Langer. "Imagine being able to take RNA or proteins orally; that would be paradigm shift."
In terms of next steps, the researchers are working to enhance the nanoparticles' drug-releasing abilities to prepare for future pre-clinical testing with insulin and other drugs. They also plan to design nanoparticles that can cross other barriers, such as the blood-brain barrier, which prevents many drugs from reaching the brain.
"If you can penetrate the mucosa in the intestine, maybe next you can penetrate the mucosa in the lungs, maybe the blood-brain barrier, maybe the placental barrier," said Farokhzad.
###
This research was supported by the Koch-Prostate Cancer Foundation Award in Nanotherapeutics; National Cancer Institute Center of Cancer Nanotechnology Excellence at MIT-Harvard; National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology Award, National Institutes of Health (HHSN268201000045C, EB000244, EB015419-01, DK53056).
Lead authors of the paper are former MIT graduate student Eric Pridgen and former BWH postdoc Frank Alexis. Other authors are Timothy Kuo, MD, BWH Division of Gastroenterology, Department of Medicine; Etgar Levy-Nissenbaum, Laboratory of Nanomedicine and Biomaterials, BWH Department of Anesthesiology; Rohit Karnik, PhD, MIT; and Richard Blumberg, MD, chief, BWH Division of Gastroenterology, Hepatology and Endoscopy.
The researchers disclose financial interests in BIND Therapeutics, Selecta Biosciences, and Blend Therapeutics, which are developing nanoparticle therapeutics.
Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $650 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH continually pushes the boundaries of medicine, including building on its legacy in transplantation by performing a partial face transplant in 2009 and the nation's first full face transplant in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom. END
Scientists develop way to successfully give nanoparticle therapeutics orally
Findings will allow for more targeted, convenient drug delivery to treat chronic diseases, like diabetes
2013-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Making a gem of a tiny crystal
2013-11-28
Making a gem of a tiny crystal
Slowly cooled DNA transforms disordered nanoparticles into orderly crystal
Nature builds flawless diamonds, sapphires and other gems. Now a Northwestern University research team is the first to build near-perfect single crystals ...
The good news about the global epidemic of dementia
2013-11-28
The good news about the global epidemic of dementia
New England Journal of Medicine perspective highlights effects of education, prevention
SEATTLE—It's rare to hear good news about dementia. But that's what a New England Journal of Medicine Perspective article ...
Physicists find a way to study coldest objects in the universe
2013-11-28
Physicists find a way to study coldest objects in the universe
They are the coldest objects in the Universe and are so fragile that even a single photon can heat and destroy them.
Known as Bose-Einstein condensates (BECs) and consisting of just a cluster ...
Improved safety measures by mental health service providers help to reduce suicide rates
2013-11-28
Improved safety measures by mental health service providers help to reduce suicide rates
Mental health service providers looking after patients at risk of suicide need to reduce absconding on in-patient wards and boost specialist community services ...
Global study reveals pandemic of untreated cancer pain due to over-regulation of pain medicines
2013-11-28
Global study reveals pandemic of untreated cancer pain due to over-regulation of pain medicines
A ground-breaking international collaborative survey, published today in Annals of Oncology, shows that more than half of the world's population live in countries where ...
Are you carrying adrenal Cushing's syndrome without knowing it?
2013-11-28
Are you carrying adrenal Cushing's syndrome without knowing it?
In light of new research, Dr. Andre Lacroix suggests genetic screening to find 'silent carriers'
Genetic research that will be published tomorrow in the New England Journal of Medicine ...
Pills of the future: Nanoparticles
2013-11-28
Pills of the future: Nanoparticles
CAMBRIDGE, MA -- Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so ...
New research shows pre-existing diabetes in pregnancy greatly increases the risk of death of the fetus or infant child
2013-11-28
New research shows pre-existing diabetes in pregnancy greatly increases the risk of death of the fetus or infant child
New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half ...
Geriatric care may help older patients become independent again after car accident or other trauma
2013-11-28
Geriatric care may help older patients become independent again after car accident or other trauma
Senior patients with traumatic injuries ranging from rib fractures to head injuries are more dependent on others for daily living activities a year later
ANN ...
EU fishing fleets reap profits while taxpayers foot the bill
2013-11-28
EU fishing fleets reap profits while taxpayers foot the bill
The European Union's taxpayers are paving the way for fishing fleets to reel in valuable catch in developing countries while fishing companies pocket the profits, according to University ...
LAST 30 PRESS RELEASES:
Fig trees convert atmospheric CO2 to stone
Intra-arterial tenecteplase for acute stroke after successful endovascular therapy
Study reveals beneficial microbes that can sustain yields in unfertilized fields
Robotic probe quickly measures key properties of new materials
Climate change cuts milk production, even when farmers cool their cows
Frozen, but not sealed: Arctic Ocean remained open to life during ice ages
Some like it cold: Cryorhodopsins
Demystifying gut bacteria with AI
Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads
Unlocking the hidden biodiversity of Europe’s villages
Planned hydrogen refuelling stations may lead to millions of euros in yearly losses
Planned C-sections increase the risk of certain childhood cancers
Adults who have survived childhood cancer are at increased risk of severe COVID-19
Drones reveal extreme coral mortality after bleaching
New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia
Native habitats hold the key to the much-loved smashed avocado’s future
Using lightning to make ammonia out of thin air
Machine learning potential-driven insights into pH-dependent CO₂ reduction
Physician associates provide safe care for diagnosed patients when directly supervised by a doctor
How game-play with robots can bring out their human side
Asthma: patient expectations influence the course of the disease
UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery
New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis
XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion
Flexible, eco-friendly electronic plastic for wearable tech, sensors
Can the Large Hadron Collider snap string theory?
Stuckeman professor’s new book explores ‘socially sustainable’ architecture
Synthetic DNA nanoparticles for gene therapy
New model to find treatments for an aggressive blood cancer
Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support
[Press-News.org] Scientists develop way to successfully give nanoparticle therapeutics orallyFindings will allow for more targeted, convenient drug delivery to treat chronic diseases, like diabetes